NSE - Delayed Quote INR

Glenmark Pharmaceuticals Limited (GLENMARK.NS)

1,079.35 -0.95 (-0.09%)
At close: April 26 at 3:30 PM GMT+5:30

Earnings Estimate

CURRENCY IN USD Current Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2022)Next Year (2023)
No. of Analysts 221919
Avg. Estimate 7.938.9938.1942.48
Low Estimate 7.18.4835.235.3
High Estimate 8.779.541.2546.6
Year Ago EPS ------38.19

Revenue Estimate

CURRENCY IN USD Current Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2022)Next Year (2023)
No. of Analysts 221919
Avg. Estimate 29.81B30.04B120.39B129.53B
Low Estimate 28.49B29.72B113.11B123.95B
High Estimate 31.14B30.36B123.55B135.11B
Year Ago Sales ------120.39B
Sales Growth (year/est) ------7.60%

Earnings History

CURRENCY IN USD 6/30/2021
EPS Est. ------8.93
EPS Actual ------10.86
Difference ------1.93
Surprise % ------21.60%

EPS Trend

CURRENCY IN USD Current Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2022)Next Year (2023)
Current Estimate 7.938.9938.1942.48
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

CURRENCY IN USD Current Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2022)Next Year (2023)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD GLENMARK.NSIndustrySectorS&P 500
Current Qtr. ------5.40%
Next Qtr. ------10.90%
Current Year ------4.50%
Next Year 11.20%----13.10%
Next 5 Years (per annum) 24.60%----10.94%
Past 5 Years (per annum) -2.97%------

Research Analysis

Analyst Price Targets

540.00 Low
646.77 Average
1,079.35 Current
795.00

Earnings

Consensus EPS
 

Related Tickers